The Innovative Medicines Initiative (IMI), a partnership between the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA) has launched a Call for proposals on COVID-19.
The scope of this fast-track call, with a budget of €45 million, remains broad and focuses on the development of:
Preventive vaccines are specifically excluded from the scope of the Call.
The GloPID-R Secretariat is a project which receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874667.